Valsartan Market Future Industry Outlook with Manufacturers (2022-2028)| Novartis, Sun Pharmaceutical, Teva, Mylan

The "Valsartan Market" report describes in detail the demand and consumption of various products related to the market growth dynamics during the forecast period of 2022-2028. A detailed market assessment of the various opportunities in the market segment is expressed in terms of quantity. These are discussed in many sections, including constraints, challenges and opportunities, regional breakdown and opportunity assessment. This global Valsartan Market report guarantees rich data on various market opportunities. The research report covers key gaming enthusiasts within the industry, CAGR value, market drivers, restraints, and international competitive strategies from the region.  The report includes strong research from expert analysts.

The global Valsartan Market is expected to grow with a CAGR greater than 8.6% during the forecast period of 2022-2028.

(Exclusive Offer: Flat 25% discount on this report)

Get a sample report with the latest industry trend analysis:

https://www.marketintelligencedata.com/reports/4682492/global-valsartan-market-insights-forecast-to-2028/inquiry?mode=Snehal

Market Overview:

Valsartan is an orally active antihypertensive drug developed in the 1990s and is a selective angiotensin II receptor blocker (ARB) that relaxes the blood vessels and thus reduces blood pressure; it is also used for treating patients with congestive heart failure and postmyocardial infarction. There are eight other ARBs that patients may be switched to if they discontinue their valsartan therapy. Valsartan was patented by Novartis Pharmaceuticals in 1996 on the US market under the name Diovan. The patent was taken off in the USA in 2012 when valsartan was distributed as a generic. Valsartan alone and in combination with other drugs are sold by 30 companies in the US market.

The major companies operating in the global Valsartan Market outlined in the report are:

Novartis,Sun Pharmaceutical,Teva,Mylan,Alembic Pharmaceuticals,Lupin,Aurobindo Pharma,Macleods Pharmaceuticals,HETERO,Torrent Pharmaceuticals,Huaren Pharmaceutical,Jubilant Pharma,Amneal Pharmaceuticals,Zhejiang Huahai Pharmaceutical,Square Pharmaceuticals,Unichem Laboratories,LG Life Sciences

Recent Development:

Teva Pharmaceutical Industries has acquired 23 companies. A total of 3 acquisitions came from private equity firms. It has also divested 9 assets. Teva Pharmaceutical Industries' largest acquisition to date was in 2015, when it acquired Allergan Generics for $40.5B. It's largest disclosed sale occurred in 2017, when it sold Teva Pharmaceutical Industries - PARAGARD to CooperSurgical for $1.1B. Teva Pharmaceutical Industries has acquired in 7 different US states, and 8 countries. The Company's most targeted sectors include life science (87%) and distribution (5%).

Novartis has acquired 31 companies, including 12 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 6 assets. Novartis' largest acquisition to date was in 2019, when it acquired The Medicines Company for $9.7B. It's largest disclosed sale occurred in 2014, when it sold Novartis Animal Health to Eli Lilly for $5.4B. Novartis has acquired in 10 different US states, and 5 countries. The Company's most targeted sectors include life science (82%) and medical products (12%).

Valsartan Market Segments:

Market Segmentation: By Type

40 mg Tablets

80 mg Tablets

160 mg Tablets

320 mg Tablets

Market Segmentation: By Application

Hypertension

Heart Failure

Heart Attack

Regions Are covered by the Global Valsartan Market 

For a comprehensive understanding of market dynamics, the Global Valsartan Market is analyzed across key geographies namely: 

North America (United States, Canada, and Mexico) 

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, and Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa).

Explore Full Report with Detailed TOC Here:

https://www.marketintelligencedata.com/reports/4682492/global-valsartan-market-insights-forecast-to-2028?mode=Snehal

The study objectives of this report are:

- To study and analyze the Global Valsartan market size (value and volume) by the company, key regions/countries, products and applications, history data from 2016 to 2021, and forecast to 2028.

- To understand the structure of Valsartan by identifying its various subsegments.

- To share detailed information about the key factors manipulating the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).

- To analyze the report with respect to individual growth trends, future prospects, and their contribution to the total market. 

- To analyze modest developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Buy now Link:

https://www.marketintelligencedata.com/report/purchase/4682492?mode=su?mode=Snehal

Scope of The Valsartan Market Report:

- The report analyses Valsartan by Type Segment.

- The report assesses the Valsartan by End User. 

- The Global Valsartan has been analyzed by Region.

- The key insights of the report have been presented through the frameworks of SWOT and Market Attractiveness charts.

- The attractiveness of the market has been presented by Region, Type and by End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analyzed in the report.

- The report provides a detailed pipeline analysis developed to cure the problem of Valsartan.

- The report tracks competitive developments, strategies, mergers and acquisitions and new product development.

-To take advantage of business owners, tap hard at Valsartan research to get a thorough understanding of current momentum.

- The report presents the analysis of Valsartan for the historical period of 2016-2021 and the forecast period of 2022-2028.

Note: All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain have been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check with the sales team.

Customizable: The Global Valsartan Market

The Global Valsartan Market report may be modified to meet your specific business needs. Because we understand our clients' needs, we offer 25% customization to any of our reports without adding additional value to all of our clients.

Thank you for taking the time to read this article… In accordance with the unique needs of your business, we may also design a custom report. Within 24 hours, we'll get in touch with you and assist you with locating the investigative reports.

Contact Us: Irfan Tamboli (Head of Sales) - MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

This release was published on openPR.